The Korean Journal of Physiology and Pharmacology

The Korean Society of Pharmacology (대한약리학회)
권호 표지
DOI QR코드

DOI QR Code

Blockade of Kv1.5 by paroxetine, an antidepressant drug

  • Lee, Hyang Mi (Department of Pharmacology, Institute for Medical Sciences, Chonbuk National University Medical School) ;
  • Hahn, Sang June (Department of Physiology, Medical Research Center, College of Medicine, The Catholic University of Korea) ;
  • Choi, Bok Hee (Department of Pharmacology, Institute for Medical Sciences, Chonbuk National University Medical School)
  • Received : 2015.08.22
  • Accepted : 2015.10.21
  • Published : 2016.01.01
Download PDF
⟨ Previous Next ⟩

Abstract

Paroxetine, a selective serotonin reuptake inhibitor (SSRI), has been reported to have an effect on several ion channels including human ether-a-go-go-related gene in a SSRI-independent manner. These results suggest that paroxetine may cause side effects on cardiac system. In this study, we investigated the effect of paroxetine on Kv1.5, which is one of cardiac ion channels. The action of paroxetine on the cloned neuronal rat Kv1.5 channels stably expressed in Chinese hamster ovary cells was investigated using the whole-cell patch-clamp technique. Paroxetine reduced Kv1.5 whole-cell currents in a reversible concentration-dependent manner, with an $IC_{50}$ value and a Hill coefficient of $4.11{\mu}M$ and 0.98, respectively. Paroxetine accelerated the decay rate of inactivation of Kv1.5 currents without modifying the kinetics of current activation. The inhibition increased steeply between -30 and 0 mV, which corresponded with the voltage range for channel opening. In the voltage range positive to 0 mV, inhibition displayed a weak voltage dependence, consistent with an electrical distance ${\delta}$ of 0.32. The binding ($k_{+1}$) and unbinding ($k_{-1}$) rate constants for paroxetine-induced block of Kv1.5 were $4.9{\mu}M^{-1}s^{-1}$ and $16.1s^{-1}$, respectively. The theoretical $K_D$ value derived by $k_{-1}/k_{+1}$ yielded $3.3{\mu}M$. Paroxetine slowed the deactivation time course, resulting in a tail crossover phenomenon when the tail currents, recorded in the presence and absence of paroxetine, were superimposed. Inhibition of Kv1.5 by paroxetine was use-dependent. The present results suggest that paroxetine acts on Kv1.5 currents as an open-channel blocker.

Keywords

References

  1. Henry JA, Alexander CA, Sener EK. Relative mortality from overdose of antidepressants. BMJ. 1995;310:221-224. https://doi.org/10.1136/bmj.310.6974.221
  2. Henry JA. Epidemiology and relative toxicity of antidepressant drugs in overdose. Drug Saf. 1997;16:374-390. https://doi.org/10.2165/00002018-199716060-00004
  3. Reilly JG, Ayis SA, Ferrier IN, Jones SJ, Thomas SH. QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet. 2000;355:1048-1052. https://doi.org/10.1016/S0140-6736(00)02035-3
  4. Scherer D, von Lowenstern K, Zitron E, Scholz EP, Bloehs R, Kathofer S, Thomas D, Bauer A, Katus HA, Karle CA, Kiesecker C. Inhibition of cardiac hERG potassium channels by tetracyclic antidepressant mianserin. Naunyn Schmiedebergs Arch Pharmacol. 2008;378:73-83. https://doi.org/10.1007/s00210-008-0289-4
  5. Hyttel J. Citalopram--pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog Neuropsychopharmacol Biol Psychiatry. 1982;6:277-295. https://doi.org/10.1016/S0278-5846(82)80179-6
  6. Wong DT, Bymaster FP, Engleman EA. Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication. Life Sci. 1995;57:411-441. https://doi.org/10.1016/0024-3205(95)00209-O
  7. Anderson IM. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J Affect Disord. 2000;58:19-36. https://doi.org/10.1016/S0165-0327(99)00092-0
  8. Montgomery SA. A meta-analysis of the efficacy and tolerability of paroxetine versus tricyclic antidepressants in the treatment of major depression. Int Clin Psychopharmacol. 2001;16:169-178. https://doi.org/10.1097/00004850-200105000-00006
  9. Wang GK, Mitchell J, Wang SY. Block of persistent late $Na^+$ currents by antidepressant sertraline and paroxetine. J Membr Biol. 2008;222:79-90. https://doi.org/10.1007/s00232-008-9103-y
  10. Dick IE, Brochu RM, Purohit Y, Kaczorowski GJ, Martin WJ, Priest BT. Sodium channel blockade may contribute to the analgesic efficacy of antidepressants. J Pain. 2007;8:315-324. https://doi.org/10.1016/j.jpain.2006.10.001
  11. Huang CJ, Harootunian A, Maher MP, Quan C, Raj CD, McCormack K, Numann R, Negulescu PA, Gonzalez JE. Characterization of voltage-gated sodium-channel blockers by electrical stimulation and fluorescence detection of membrane potential. Nat Biotechnol. 2006;24:439-446. https://doi.org/10.1038/nbt1194
  12. Kobayashi T, Washiyama K, Ikeda K. Inhibition of G protein-activated inwardly rectifying $K^+$ channels by the antidepressant paroxetine. J Pharmacol Sci. 2006;102:278-287. https://doi.org/10.1254/jphs.FP0060708
  13. Thummler S, Duprat F, Lazdunski M. Antipsychotics inhibit TREK but not TRAAK channels. Biochem Biophys Res Commun. 2007;354:284-289. https://doi.org/10.1016/j.bbrc.2006.12.199
  14. Lee SH, Sung MJ, Lee HM, Chu D, Hahn SJ, Jo SH, Choe H, Choi BH. Blockade of HERG human $K^+$ channels by the antidepressant drug paroxetine. Biol Pharm Bull. 2014;37:1495-1504. https://doi.org/10.1248/bpb.b14-00244
  15. Wang Z, Fermini B, Nattel S. Sustained depolarization-induced outward current in human atrial myocytes. Evidence for a novel delayed rectifier $K^+$ current similar to Kv1.5 cloned channel currents. Circ Res. 1993;73:1061-1076. https://doi.org/10.1161/01.RES.73.6.1061
  16. Swanson R, Marshall J, Smith JS, Williams JB, Boyle MB, Folander K, Luneau CJ, Antanavage J, Oliva C, Buhrow SA, Bennet C, Stein RB, Kaczmarek LK. Cloning and expression of cDNA and genomic clones encoding three delayed rectifier potassium channels in rat brain. Neuron. 1990;4:929-939. https://doi.org/10.1016/0896-6273(90)90146-7
  17. Colatsky TJ, Follmer CH, Starmer CF. Channel specificity in antiarrhythmic drug action. Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias. Circulation. 1990;82:2235-2242. https://doi.org/10.1161/01.CIR.82.6.2235
  18. Li GR, Feng J, Wang Z, Fermini B, Nattel S. Adrenergic modulation of ultrarapid delayed rectifier $K^+$ current in human atrial myocytes. Circ Res. 1996;78:903-915. https://doi.org/10.1161/01.RES.78.5.903
  19. Cobbe SM. Incidence and risks associated with atrial fibrillation. Pacing Clin Electrophysiol. 1994;17:1005-1010. https://doi.org/10.1111/j.1540-8159.1994.tb01453.x
  20. Choi BH, Choi JS, Jeong SW, Hahn SJ, Yoon SH, Jo YH, Kim MS. Direct block by bisindolylmaleimide of rat Kv1.5 expressed in Chinese hamster ovary cells. J Pharmacol Exp Ther. 2000;293:634-640.
  21. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 1981;391:85-100. https://doi.org/10.1007/BF00656997
  22. Snyders DJ, Yeola SW. Determinants of antiarrhythmic drug action. Electrostatic and hydrophobic components of block of the human cardiac hKv1.5 channel. Circ Res. 1995;77:575-583. https://doi.org/10.1161/01.RES.77.3.575
  23. Woodhull AM. Ionic blockage of sodium channels in nerve. J Gen Physiol. 1973;61:687-708. https://doi.org/10.1085/jgp.61.6.687
  24. Snyders DJ, Tamkun MM, Bennett PB. A rapidly activating and slowly inactivating potassium channel cloned from human heart. Functional analysis after stable mammalian cell culture expression. J Gen Physiol. 1993;101:513-543. https://doi.org/10.1085/jgp.101.4.513
  25. Valenzuela C, Delpon E, Franqueza L, Gay P, Perez O, Tamargo J, Snyders DJ. Class III antiarrhythmic effects of zatebradine. Time-, state-, use-, and voltage-dependent block of hKv1.5 channels. Circulation. 1996;94:562-570. https://doi.org/10.1161/01.CIR.94.3.562
  26. Delpon E, Valenzuela C, Gay P, Franqueza L, Snyders DJ, Tamargo J. Block of human cardiac Kv1.5 channels by loratadine: voltage-, time- and use-dependent block at concentrations above therapeutic levels. Cardiovasc Res. 1997;35:341-350. https://doi.org/10.1016/S0008-6363(97)00121-1
  27. Franqueza L, Valenzuela C, Delpon E, Longobardo M, Caballero R, Tamargo J. Effects of propafenone and 5-hydroxy-propafenone on hKv1.5 channels. Br J Pharmacol. 1998;125:969-978. https://doi.org/10.1038/sj.bjp.0702129
  28. Choi JS, Hahn SJ, Rhie DJ, Yoon SH, Jo YH, Kim MS. Mechanism of fluoxetine block of cloned voltage-activated potassium channel Kv1.3. J Pharmacol Exp Ther. 1999;291:1-6.
  29. Vasskog T, Berger U, Samuelsen PJ, Kallenborn R, Jensen E. Selective serotonin reuptake inhibitors in sewage influents and effluents from Tromso, Norway. J Chromatogr A. 2006;1115:187-195. https://doi.org/10.1016/j.chroma.2006.02.091
  30. Snyders J, Knoth KM, Roberds SL, Tamkun MM. Time-, voltage-, and state-dependent block by quinidine of a cloned human cardiac potassium channel. Mol Pharmacol. 1992;41:322-330.
  31. Lee HM, Hahn SJ, Choi BH. Open channel block of Kv1.5 currents by citalopram. Acta Pharmacol Sin. 2010;31:429-435. https://doi.org/10.1038/aps.2010.14
  32. Baldessarini R. Drugs and the treatment of psychiatric disorders: depression and anxiety disorders. In: Hardman JG, Limbird LE, Gilman AG, editors. The pharmacological basis of therapeutics. New York: McGraw-Hill; 2001. p.447-484.
  33. Arechiga IA, Barrio-Echavarria GF, Rodriguez-Menchaca AA, Moreno-Galindo EG, Decher N, Tristani-Firouzi M, Sanchez-Chapula JA, Navarro-Polanco RA. Kv1.5 open channel block by the antiarrhythmic drug disopyramide: molecular determinants of block. J Pharmacol Sci. 2008;108:49-55. https://doi.org/10.1254/jphs.08084FP
  34. Fedida D. Gating charge and ionic currents associated with quinidine block of human Kv1.5 delayed rectifier channels. J Physiol. 1997;499:661-675. https://doi.org/10.1113/jphysiol.1997.sp021959

Cited by

  1. Enhancement of 5-HT 2A receptor function and blockade of Kv1.5 by MK801 and ketamine: implications for PCP derivative-induced disease models vol.50, pp.4, 2016, https://doi.org/10.1038/s12276-018-0073-6
  2. Challenges Faced with Small Molecular Modulators of Potassium Current Channel Isoform Kv1.5 vol.10, pp.1, 2020, https://doi.org/10.3390/biom10010010
  3. Inhibitory effect of the selective serotonin reuptake inhibitor paroxetine on human Kv1.3 channels vol.912, pp.None, 2021, https://doi.org/10.1016/j.ejphar.2021.174567